Central Alerting System
View Alert


Originator: National Patient Safety Alert - National Supply Disruption Response

Issue date: 13-Oct-2026 16:55:12

This alert has been issued to:
  • Care Trusts
  • Mental Health Trusts
  • Specialists Trusts
  • Learning Disabilities Trusts
  • Mental Health & Social Care Trusts
  • Ambulance Trusts
  • Mental Health & Learning Disabilities Trusts
  • Acute Trusts
  • Community Trusts

  • Other contacts
  • Independent Healthcare Providers (registered with CAS)
  • Clinical Commissioning Groups
  • NHS Regional Offices
  • Social Care Providers (registered with CAS)
  • Special Health Authorities
  • Territorial CMOs in Northern Ireland, Scotland & Wales
  • GP - Locum
  • NHS 111 and Out of hours providers
  • Dispensing GP Practices
  • GP Practices
  • Integrated Care Boards
  • DHSC Supply Disruption - Medicines
  • Community Pharmacy
  • Primary Care Networks
  • GP Practices 1

Action category: Action

Title: SUPPLY DISTRUPTION FOR NOVA BIOMEDICAL STATSTRIP BLOOD KETONE TEST STRIPS

Broadcast content:

Nova has identified quality issues affecting specified lots of StatStrip ketone test strips. The affected lots have been associated with quality-control (QC) failures and Nova has initiated a recall, advising that these lots should not be used. Lot numbers can be found on Nova’s Field Safety Notice. Nova has paused distribution of affected lots and advised that any further lots found to fail QC testing should also be withdrawn from use. This may result in further disruption to blood ketone point-of-care testing. Nova currently expects new product to be available for shipment to the UK during the week of 26 October 2026.

This National Patient Safety Alert provides further background, clinical information and actions for providers.



Additional information: NHS England Regions: Please cascade this alert to Community Pharmacy

Alert reference: NatPSA/2026/007/NSDR

Action underway deadline: 15-Oct-2026

Action complete deadline: 20-Oct-2026

Attachments:

Contact our helpdesk

Email: safetyalerts@mhra.gov.uk

Medicines and Healthcare products Regulatory Agency